Microdeletions in 9p21.3 induce false negative results in CDKN2A FISH analysis of Ewing sarcoma

被引:33
作者
Savola, S. [1 ]
Nardi, F. [2 ]
Scotlandi, K. [2 ]
Picci, P. [2 ]
Knuutila, S. [1 ]
机构
[1] Univ Helsinki, Haartman Inst, Dept Pathol, FI-00014 Helsinki, Finland
[2] Ist Ortoped Rizzoli, Lab Ric Oncol, Bologna, Italy
关键词
D O I
10.1159/000109614
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Deletion of the CDKN2A locus at 9p21.3 has been reported to be a poor prognostic sign in the Ewing sarcoma family of tumours. In clinical applications CDKN2A deletion is primarily detected using fluorescent in situ hybridisation (FISH) with a commercial probe, size similar to 190 kb. Due to limitations in resolution, FISH analysis may fail to detect microdeletions smaller than 190 kb. In the present study, we performed 44K array comparative genomic hybridisation (CGH) on eleven Ewing sarcoma cell lines and 26 tissue samples in order to define the sizes of 9p21.3 deletions. Microarray CGH analysis revealed 9p21.3 deletions encompassing the CDKN2A locus in eight cell lines (73%) and in six tumours (23%). In four cases (two cell lines and two tissue samples) the deletion was less than 190 kb in size. In one cell line sample, we detected a microdeletion of similar to 58 kb in 9p21.3 harbouring the CDKN2A locus. We confirmed this result using 244K microarray CGH and TaqMan quantitative RT-PCR analysis and further performed FISH analysis on this cell line sample. Here, we show that CDKN2A FISH analysis can give false negative results in cases with small microdeletions. Our results suggest that new and more accurate FISH methods should be developed for detection of deletions in the CDKN2A locus. Copyright (C) 2007 S. Karger AG, Basel.
引用
收藏
页码:21 / 26
页数:6
相关论文
共 16 条
[1]   Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification [J].
Bunyan, DJ ;
Eccles, DM ;
Sillibourne, J ;
Wilkins, E ;
Thomas, NS ;
Shea-Simonds, J ;
Duncan, PJ ;
Curtis, CE ;
Robinson, DO ;
Harvey, JF ;
Cross, NCP .
BRITISH JOURNAL OF CANCER, 2004, 91 (06) :1155-1159
[2]   FREQUENCY OF HOMOZYGOUS DELETION AT P16/CDKN2 IN PRIMARY HUMAN TUMORS [J].
CAIRNS, P ;
POLASCIK, TJ ;
EBY, Y ;
TOKINO, K ;
CALIFANO, J ;
MERLO, A ;
MAO, L ;
HERATH, J ;
JENKINS, R ;
WESTRA, W ;
RUTTER, JL ;
BUCKLER, A ;
GABRIELSON, E ;
TOCKMAN, M ;
CHO, KR ;
HEDRICK, L ;
BOVA, GS ;
ISAACS, W ;
KOCH, W ;
SCHWAB, D ;
SIDRANSKY, D .
NATURE GENETICS, 1995, 11 (02) :210-212
[3]  
Hogervorst FBL, 2003, CANCER RES, V63, P1449
[4]   Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion:: A highly lethal subset associated with poor chemoresponse [J].
Huang, HY ;
Illei, PB ;
Zhao, ZQ ;
Mazumdar, M ;
Huvos, AG ;
Healey, JH ;
Wexler, LH ;
Gorlick, R ;
Meyers, P ;
Ladanyi, M .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (03) :548-558
[5]   Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors [J].
Kovar, H ;
Jug, G ;
Aryee, DNT ;
Zoubek, A ;
Ambros, P ;
Gruber, B ;
Windhager, R ;
Gadner, H .
ONCOGENE, 1997, 15 (18) :2225-2232
[6]   Role of the p16 tumor suppressor gene in cancer [J].
Liggett, WH ;
Sidransky, D .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (03) :1197-1206
[7]   Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method [J].
Livak, KJ ;
Schmittgen, TD .
METHODS, 2001, 25 (04) :402-408
[8]   Molecular analysis of the 9p21 locus and p53 genes in Ewing family tumors [J].
López-Guerrero, JA ;
Pellín, A ;
Noguera, R ;
Carda, C ;
Llombart-Bosch, A .
LABORATORY INVESTIGATION, 2001, 81 (06) :803-814
[9]   To cycle or not to cycle: A critical decision in cancer [J].
Malumbres, M ;
Barbacid, M .
NATURE REVIEWS CANCER, 2001, 1 (03) :222-231
[10]   The expression of ccn3(nov) gene in musculoskeletal tumors [J].
Manara, MC ;
Perbal, B ;
Benini, S ;
Strammiello, R ;
Cerisano, V ;
Perdichizzi, S ;
Serra, M ;
Astolfi, A ;
Bertoni, F ;
Alami, J ;
Yeger, H ;
Picci, P ;
Scotlandi, K .
AMERICAN JOURNAL OF PATHOLOGY, 2002, 160 (03) :849-859